Layered Double Hydroxide-Based Nanocarriers for Drug Delivery

Biocompatible clay materials have attracted particular attention as the efficient drug delivery systems (DDS). In this article, we review developments in the use of layered double hydroxides (LDHs) for controlled drug release and delivery. We show how advances in the ability to synthesize intercalat...

Full description

Saved in:
Bibliographic Details
Main Authors: Xue Bi (Author), Hui Zhang (Author), Liguang Dou (Author)
Format: Book
Published: MDPI AG, 2014-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_c72f3107f14e4bd6b4e147a0d2e79a68
042 |a dc 
100 1 0 |a Xue Bi  |e author 
700 1 0 |a Hui Zhang  |e author 
700 1 0 |a Liguang Dou  |e author 
245 0 0 |a Layered Double Hydroxide-Based Nanocarriers for Drug Delivery 
260 |b MDPI AG,   |c 2014-06-01T00:00:00Z. 
500 |a 1999-4923 
500 |a 10.3390/pharmaceutics6020298 
520 |a Biocompatible clay materials have attracted particular attention as the efficient drug delivery systems (DDS). In this article, we review developments in the use of layered double hydroxides (LDHs) for controlled drug release and delivery. We show how advances in the ability to synthesize intercalated structures have a significant influence on the development of new applications of these materials. We also show how modification and/or functionalization can lead to new biotechnological and biomedical applications. This review highlights the most recent progresses in research on LDH-based controlled drug delivery systems, focusing mainly on: (i) DDS with cardiovascular drugs as guests; (ii) DDS with anti-inflammatory drugs as guests; and (iii) DDS with anti-cancer drugs as guests. Finally, future prospects for LDH-based drug carriers are also discussed. 
546 |a EN 
690 |a layered double hydroxides 
690 |a drug delivery system 
690 |a controlled release 
690 |a intercalation assembly 
690 |a cardiovascular drug 
690 |a anti-inflammatory drug 
690 |a anti-cancer drug 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 6, Iss 2, Pp 298-332 (2014) 
787 0 |n http://www.mdpi.com/1999-4923/6/2/298 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/c72f3107f14e4bd6b4e147a0d2e79a68  |z Connect to this object online.